![The Next Urban Revolution: Reimagining Cities for an Aging Population](/sites/default/files/oembed_thumbnails/IMHZP1CVxJo9IlNRyB9upqwQLve2SG1Mesbcyp7LIoM.jpg)
The Next Urban Revolution: Reimagining Cities for an Aging Population
![Real Estate: Structural and Cyclical Disruption](/sites/default/files/oembed_thumbnails/FDF66T41s6BfAhQ8biPuoMqm1RD_eTdfoB5_GUNGpT4.jpg)
Real Estate: Structural and Cyclical Disruption
![A Conversation with Scott Gottlieb, Commissioner, U.S. Food and Drug Administration](/sites/default/files/oembed_thumbnails/hz9Z-gcJY0t-n6C3FXWbCwU6zs7ftXBNFDOFy-L7I6M.jpg)
A Conversation with Scott Gottlieb, Commissioner, U.S. Food and Drug Administration
![Finding a Cure for the Cost of Durable Therapies](/sites/default/files/oembed_thumbnails/JxMDFV-25yha1o9dzYNgdwEPR2nEYKsFP0jRdWkovEo.jpg)
Finding a Cure for the Cost of Durable Therapies
![Austin, Texas and Idaho Falls, Idaho Top Milken Institute’s 2024 Annual Ranking of Best-Performing Cities](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
Austin, Texas and Idaho Falls, Idaho Top Milken Institute’s 2024 Annual Ranking of Best-Performing Cities
![Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
![Revitalizing the American Dream through Housing Access](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
Revitalizing the American Dream through Housing Access
![Journey toward Collective Impact](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)